摘要
目的分析奥曲肽治疗腔镜胆囊切除术后早期炎性肠梗阻临床疗效。方法选取60例腔镜胆囊切除术后早期炎性肠梗阻,随机分为对照组(30)与治疗组(30),对照组采取常规保守治疗,治疗组加用奥曲肽,对比两组临床疗效。结果治疗组肛门排气时间、症状缓解时间、住院时间短于对照组(P<0.05)。治疗组总有效率为93.33%,对照组为73.33%,治疗组高于对照组(P<0.05)。结论对腔镜胆囊切除术后早期炎性肠梗阻患者采用奥曲肽治疗,效果显著。
Objective To analyze the clinical efficacy of endoscopic cholecystectomy octreotide EPISB0. Methods 60 cases of laparoscopic cholecystectomy EPISBO randomly divided into control group(30)and the treatment group(30),the control group received conventional conservative treatment,the treatment group with octreotide,comparative clinical efficacy. Results The treatment group flatus,symptom relief time,shorter hospital stay than the control group(P〈0.05). The total effective rate was 93.33%,73.33% in the control group,the treatment group was higher(P〈0.05). Conclusion Laparoscopic cholecystectomy in patients with early postoperative inflammatory intestinal obstruction using octreotide,the effect is significant.
出处
《中国卫生标准管理》
2016年第1期72-73,共2页
China Health Standard Management
关键词
炎性肠梗阻
腔镜胆囊切除术
临床疗效
Inflammatory bowel obstruction
Laparoscopic cholecystectomy
Clinical efficacy